Inogen Inc Stock Today

INGN Stock  USD 7.45  0.43  5.46%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Inogen is selling at 7.45 as of the 17th of March 2025; that is 5.46 percent decrease since the beginning of the trading day. The stock's open price was 7.88. Inogen has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Note, on December 13, 2018, Representative Lamar Smith of US Congress acquired under $15k worth of Inogen Inc's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
14th of February 2014
Category
Healthcare
Classification
Health Care
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. The company has 26.53 M outstanding shares of which 665.89 K shares are currently shorted by private and institutional investors with about 1.98 trading days to cover. More on Inogen Inc

Moving together with Inogen Stock

  0.67RMD ResMed IncPairCorr

Moving against Inogen Stock

  0.46LUNG Pulmonx CorpPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Inogen Stock Highlights

ESG Sustainability
Environmental
Governance
Social
PresidentBart Sanford
Thematic Ideas
(View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Baby Boomer Prospects, Trump Equities, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.021.1334
Moderately Down
Slightly volatile
Gross Profit Margin0.520.4609
Moderately Up
Slightly volatile
Total Current Liabilities44.8 M76.7 M
Way Down
Slightly volatile
Non Current Liabilities Total29.3 M45.6 M
Way Down
Slightly volatile
Total Assets294.4 M296.2 M
Slightly Down
Slightly volatile
Total Current Assets204.8 M185.5 M
Significantly Up
Slightly volatile
Debt Levels
Inogen can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Inogen's financial leverage. It provides some insight into what part of Inogen's total assets is financed by creditors.
Liquidity
Inogen Inc currently holds 19.41 M in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. Inogen Inc has a current ratio of 5.21, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Inogen's use of debt, we should always consider it together with its cash and equity.

Other Cashflows From Financing Activities

251,750
Inogen Inc (INGN) is traded on NASDAQ Exchange in USA. It is located in 859 Ward Drive, Goleta, CA, United States, 93111 and employs 766 people. Inogen is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 197.64 M. Inogen Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 26.53 M outstanding shares of which 665.89 K shares are currently shorted by private and institutional investors with about 1.98 trading days to cover. Inogen Inc currently holds about 223.62 M in cash with 5.91 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Inogen Probability Of Bankruptcy
Ownership Allocation
Inogen Inc has a total of 26.53 Million outstanding shares. The majority of Inogen Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inogen to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inogen Inc. Please pay attention to any change in the institutional holdings of Inogen Inc as this could imply that something significant has changed or is about to change at the company. On December 13, 2018, Representative Lamar Smith of US Congress acquired under $15k worth of Inogen Inc's common stock.
Check Inogen Ownership Details

Inogen Stock Institutional Holders

InstituionRecorded OnShares
State Street Corp2024-12-31
524 K
Renaissance Technologies Corp2024-12-31
492.9 K
Morgan Stanley - Brokerage Accounts2024-12-31
472.3 K
Aqr Capital Management Llc2024-12-31
433.7 K
New York State Common Retirement Fund2024-12-31
410.3 K
Federated Hermes Inc2024-12-31
404.3 K
Prudential Financial Inc2024-12-31
360 K
Royce & Associates, Lp2024-12-31
311.2 K
Jacobs Levy Equity Management, Inc.2024-12-31
303.5 K
Camber Capital Management Llc2024-12-31
M
Blackrock Inc2024-12-31
1.7 M
View Inogen Diagnostics

Inogen Historical Income Statement

At this time, Inogen's Interest Expense is very stable compared to the past year. As of the 17th of March 2025, Research Development is likely to grow to about 22.7 M, while Depreciation And Amortization is likely to drop about 14.9 M. View More Fundamentals

Inogen Stock Against Markets

Inogen Corporate Management

Nabil ShabshabPres CEOProfile
Vijay PaliwalSenior EnablementProfile
Adrien MithalalSenior DevelopmentProfile
Agnes LeeVP PlanningProfile
Philip CorrinSenior ChainProfile
When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.873
Earnings Share
(1.52)
Revenue Per Share
14.192
Quarterly Revenue Growth
0.055
Return On Assets
(0.08)
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.